| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | adenylate cyclase activity | 7.00e-07 | 18 | 80 | 4 | GO:0004016 | |
| GeneOntologyMolecularFunction | cyclase activity | 2.39e-06 | 24 | 80 | 4 | GO:0009975 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 2.83e-06 | 25 | 80 | 4 | GO:0016849 | |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 1.57e-04 | 5 | 80 | 2 | GO:0008294 | |
| GeneOntologyBiologicalProcess | cAMP biosynthetic process | 6.12e-08 | 11 | 78 | 4 | GO:0006171 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide biosynthetic process | 1.59e-06 | 23 | 78 | 4 | GO:0009190 | |
| GeneOntologyBiologicalProcess | cAMP metabolic process | 2.25e-06 | 25 | 78 | 4 | GO:0046058 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 1.86e-05 | 86 | 78 | 5 | GO:0007193 | |
| GeneOntologyBiologicalProcess | cyclic purine nucleotide metabolic process | 2.29e-05 | 44 | 78 | 4 | GO:0052652 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide metabolic process | 2.51e-05 | 45 | 78 | 4 | GO:0009187 | |
| GeneOntologyBiologicalProcess | cellular response to forskolin | 4.08e-05 | 18 | 78 | 3 | GO:1904322 | |
| GeneOntologyBiologicalProcess | response to forskolin | 4.83e-05 | 19 | 78 | 3 | GO:1904321 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR2T8 GPRASP1 KLF16 OR2T33 OR5B17 MUC19 APLP2 OR2T12 ADGRV1 ADGRE1 GABBR2 ADGRL2 ADCY2 ADCY5 ADCY6 ADCY7 | 5.55e-05 | 1395 | 78 | 16 | GO:0007186 |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 7.35e-05 | 59 | 78 | 4 | GO:0045761 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 8.61e-05 | 191 | 78 | 6 | GO:0007189 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 1.04e-04 | 286 | 78 | 7 | GO:0007188 | |
| GeneOntologyBiologicalProcess | regulation of cyclase activity | 1.36e-04 | 69 | 78 | 4 | GO:0031279 | |
| GeneOntologyBiologicalProcess | maintenance of animal organ identity | 1.40e-04 | 5 | 78 | 2 | GO:0048496 | |
| GeneOntologyBiologicalProcess | regulation of lyase activity | 1.69e-04 | 73 | 78 | 4 | GO:0051339 | |
| GeneOntologyCellularComponent | USH2 complex | 8.21e-05 | 4 | 78 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 2.04e-04 | 6 | 78 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 2.04e-04 | 6 | 78 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | stereocilium membrane | 2.04e-04 | 6 | 78 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | periciliary membrane compartment | 2.04e-04 | 6 | 78 | 2 | GO:1990075 | |
| GeneOntologyCellularComponent | stereocilia coupling link | 3.79e-04 | 8 | 78 | 2 | GO:0002139 | |
| GeneOntologyCellularComponent | basement membrane | 1.13e-03 | 122 | 78 | 4 | GO:0005604 | |
| Domain | Adcy_conserved_dom | 3.58e-09 | 6 | 75 | 4 | IPR009398 | |
| Domain | DUF1053 | 3.58e-09 | 6 | 75 | 4 | PF06327 | |
| Domain | AC_N | 1.66e-08 | 8 | 75 | 4 | IPR032628 | |
| Domain | Adcy | 1.66e-08 | 8 | 75 | 4 | IPR030672 | |
| Domain | AC_N | 1.66e-08 | 8 | 75 | 4 | PF16214 | |
| Domain | A/G_cyclase_CS | 5.49e-07 | 17 | 75 | 4 | IPR018297 | |
| Domain | Nucleotide_cyclase | 7.03e-07 | 18 | 75 | 4 | IPR029787 | |
| Domain | - | 7.03e-07 | 18 | 75 | 4 | 3.30.70.1230 | |
| Domain | GUANYLATE_CYCLASE_1 | 8.88e-07 | 19 | 75 | 4 | PS00452 | |
| Domain | Guanylate_cyc | 8.88e-07 | 19 | 75 | 4 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 8.88e-07 | 19 | 75 | 4 | PS50125 | |
| Domain | A/G_cyclase | 8.88e-07 | 19 | 75 | 4 | IPR001054 | |
| Domain | CYCc | 8.88e-07 | 19 | 75 | 4 | SM00044 | |
| Domain | GPS | 1.02e-05 | 34 | 75 | 4 | SM00303 | |
| Domain | GPS | 1.14e-05 | 35 | 75 | 4 | PF01825 | |
| Domain | GPS | 1.28e-05 | 36 | 75 | 4 | PS50221 | |
| Domain | GPS | 1.43e-05 | 37 | 75 | 4 | IPR000203 | |
| Domain | Lectin_gal-bd_dom | 1.58e-04 | 5 | 75 | 2 | IPR000922 | |
| Domain | Gal_Lectin | 1.58e-04 | 5 | 75 | 2 | PF02140 | |
| Domain | SUEL_LECTIN | 1.58e-04 | 5 | 75 | 2 | PS50228 | |
| Domain | EGF_LAM_2 | 2.34e-04 | 30 | 75 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 2.34e-04 | 30 | 75 | 3 | PS01248 | |
| Domain | Pept_C14A_CASP1-typ | 3.30e-04 | 7 | 75 | 2 | IPR017350 | |
| Domain | EGF_Lam | 3.71e-04 | 35 | 75 | 3 | SM00180 | |
| Domain | Laminin_EGF | 4.74e-04 | 38 | 75 | 3 | IPR002049 | |
| Domain | CASPASE_HIS | 8.55e-04 | 11 | 75 | 2 | PS01121 | |
| Domain | TIL | 1.02e-03 | 12 | 75 | 2 | PF01826 | |
| Domain | Caspase_cys_AS | 1.02e-03 | 12 | 75 | 2 | IPR033139 | |
| Domain | Caspase_his_AS | 1.02e-03 | 12 | 75 | 2 | IPR016129 | |
| Domain | CASPASE_P10 | 1.02e-03 | 12 | 75 | 2 | PS50207 | |
| Domain | CASPASE_CYS | 1.02e-03 | 12 | 75 | 2 | PS01122 | |
| Domain | Pept_C14_p10 | 1.02e-03 | 12 | 75 | 2 | IPR002138 | |
| Domain | C8 | 1.02e-03 | 12 | 75 | 2 | PF08742 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 1.06e-03 | 50 | 75 | 3 | PS00650 | |
| Domain | 7tm_2 | 1.06e-03 | 50 | 75 | 3 | PF00002 | |
| Domain | CASc | 1.21e-03 | 13 | 75 | 2 | SM00115 | |
| Domain | Unchr_dom_Cys-rich | 1.21e-03 | 13 | 75 | 2 | IPR014853 | |
| Domain | Pept_C14A | 1.21e-03 | 13 | 75 | 2 | IPR015917 | |
| Domain | C8 | 1.21e-03 | 13 | 75 | 2 | SM00832 | |
| Domain | Pept_C14_p20 | 1.40e-03 | 14 | 75 | 2 | IPR001309 | |
| Domain | Caspase-like_dom | 1.40e-03 | 14 | 75 | 2 | IPR029030 | |
| Domain | TIL_dom | 1.40e-03 | 14 | 75 | 2 | IPR002919 | |
| Domain | CASPASE_P20 | 1.40e-03 | 14 | 75 | 2 | PS50208 | |
| Domain | - | 1.40e-03 | 14 | 75 | 2 | 3.40.50.1460 | |
| Domain | EGF_CA | 1.47e-03 | 122 | 75 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.56e-03 | 124 | 75 | 4 | IPR001881 | |
| Domain | GPCR_2_secretin-like | 1.81e-03 | 60 | 75 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 1.81e-03 | 60 | 75 | 3 | IPR017981 | |
| Domain | VWD | 1.84e-03 | 16 | 75 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.84e-03 | 16 | 75 | 2 | IPR001846 | |
| Domain | Laminin_N | 1.84e-03 | 16 | 75 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 1.84e-03 | 16 | 75 | 2 | PS51117 | |
| Domain | VWFD | 1.84e-03 | 16 | 75 | 2 | PS51233 | |
| Domain | Laminin_N | 1.84e-03 | 16 | 75 | 2 | PF00055 | |
| Domain | VWD | 1.84e-03 | 16 | 75 | 2 | PF00094 | |
| Domain | LamNT | 1.84e-03 | 16 | 75 | 2 | SM00136 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 1.89e-03 | 61 | 75 | 3 | PS50261 | |
| Domain | TY | 2.08e-03 | 17 | 75 | 2 | SM00211 | |
| Domain | - | 2.08e-03 | 17 | 75 | 2 | 4.10.800.10 | |
| Domain | THYROGLOBULIN_1_2 | 2.08e-03 | 17 | 75 | 2 | PS51162 | |
| Domain | Thyroglobulin_1 | 2.08e-03 | 17 | 75 | 2 | IPR000716 | |
| Domain | Thyroglobulin_1 | 2.08e-03 | 17 | 75 | 2 | PF00086 | |
| Domain | THYROGLOBULIN_1_1 | 2.08e-03 | 17 | 75 | 2 | PS00484 | |
| Domain | - | 2.34e-03 | 18 | 75 | 2 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 2.34e-03 | 18 | 75 | 2 | IPR020901 | |
| Domain | KU | 2.34e-03 | 18 | 75 | 2 | SM00131 | |
| Domain | EGF_3 | 2.55e-03 | 235 | 75 | 5 | PS50026 | |
| Domain | BPTI_KUNITZ_2 | 2.60e-03 | 19 | 75 | 2 | PS50279 | |
| Domain | Kunitz_BPTI | 2.60e-03 | 19 | 75 | 2 | PF00014 | |
| Domain | BPTI_KUNITZ_1 | 2.60e-03 | 19 | 75 | 2 | PS00280 | |
| Domain | EGF-like_dom | 3.27e-03 | 249 | 75 | 5 | IPR000742 | |
| Domain | Growth_fac_rcpt_ | 3.59e-03 | 156 | 75 | 4 | IPR009030 | |
| Domain | EGF_1 | 3.62e-03 | 255 | 75 | 5 | PS00022 | |
| Domain | Kunitz_BPTI | 3.81e-03 | 23 | 75 | 2 | IPR002223 | |
| Domain | EGF-like_CS | 4.00e-03 | 261 | 75 | 5 | IPR013032 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 3.68e-08 | 10 | 53 | 4 | M19522 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 3.68e-08 | 10 | 53 | 4 | MM14668 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY | 6.87e-08 | 29 | 53 | 5 | M47627 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 1.73e-07 | 14 | 53 | 4 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 1.73e-07 | 14 | 53 | 4 | M750 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 2.36e-07 | 15 | 53 | 4 | M47794 | |
| Pathway | PID_LPA4_PATHWAY | 2.36e-07 | 15 | 53 | 4 | M56 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 2.36e-07 | 15 | 53 | 4 | M47504 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 3.13e-07 | 16 | 53 | 4 | M47645 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 3.13e-07 | 16 | 53 | 4 | M47650 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 3.13e-07 | 16 | 53 | 4 | MM14492 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 3.13e-07 | 16 | 53 | 4 | M39849 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 4.09e-07 | 17 | 53 | 4 | M26995 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 4.09e-07 | 17 | 53 | 4 | M47544 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 5.35e-07 | 43 | 53 | 5 | M954 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 6.02e-07 | 44 | 53 | 5 | MM15709 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 8.25e-07 | 20 | 53 | 4 | M759 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.79e-06 | 24 | 53 | 4 | M47520 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 2.50e-06 | 26 | 53 | 4 | M47553 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 2.50e-06 | 26 | 53 | 4 | MM14495 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 2.89e-06 | 60 | 53 | 5 | MM15708 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 2.89e-06 | 60 | 53 | 5 | M976 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 2.93e-06 | 27 | 53 | 4 | M47518 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 2.93e-06 | 27 | 53 | 4 | M47519 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 3.41e-06 | 28 | 53 | 4 | M47647 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 3.94e-06 | 29 | 53 | 4 | M47515 | |
| Pathway | KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 5.20e-06 | 31 | 53 | 4 | M47507 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY | 5.92e-06 | 32 | 53 | 4 | M47506 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 6.72e-06 | 33 | 53 | 4 | MM15058 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 6.72e-06 | 33 | 53 | 4 | M11575 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 8.55e-06 | 35 | 53 | 4 | M47969 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.07e-05 | 37 | 53 | 4 | M749 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 1.33e-05 | 39 | 53 | 4 | MM14496 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 1.63e-05 | 41 | 53 | 4 | M512 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 1.97e-05 | 43 | 53 | 4 | M29837 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 1.97e-05 | 43 | 53 | 4 | M933 | |
| Pathway | KEGG_GAP_JUNCTION | 2.14e-05 | 90 | 53 | 5 | M4013 | |
| Pathway | REACTOME_GPER1_SIGNALING | 2.37e-05 | 45 | 53 | 4 | M45008 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 2.58e-05 | 46 | 53 | 4 | M39828 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 3.07e-05 | 48 | 53 | 4 | M10775 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 4.22e-05 | 52 | 53 | 4 | M920 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 4.90e-05 | 54 | 53 | 4 | M26911 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 5.27e-05 | 55 | 53 | 4 | M39763 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 6.39e-05 | 113 | 53 | 5 | M27471 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 9.00e-05 | 63 | 53 | 4 | M8 | |
| Pathway | PID_LYSOPHOSPHOLIPID_PATHWAY | 1.02e-04 | 65 | 53 | 4 | M15 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.14e-04 | 205 | 53 | 6 | M752 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 1.44e-04 | 71 | 53 | 4 | MM14491 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 2.01e-04 | 144 | 53 | 5 | MM14501 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 2.43e-04 | 150 | 53 | 5 | M27440 | |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 2.88e-04 | 85 | 53 | 4 | M3578 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 3.58e-04 | 90 | 53 | 4 | M6467 | |
| Pathway | WP_G_PROTEIN_SIGNALING_PATHWAYS | 3.58e-04 | 90 | 53 | 4 | MM15882 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 3.58e-04 | 90 | 53 | 4 | M835 | |
| Pathway | WP_G_PROTEIN_SIGNALING | 3.74e-04 | 91 | 53 | 4 | M39426 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 4.40e-04 | 95 | 53 | 4 | M29842 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 5.04e-04 | 270 | 53 | 6 | M15514 | |
| Pathway | WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS | 5.19e-04 | 42 | 53 | 3 | M39703 | |
| Pathway | WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS | 5.19e-04 | 42 | 53 | 3 | MM15822 | |
| Pathway | KEGG_MELANOGENESIS | 5.55e-04 | 101 | 53 | 4 | M7761 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 5.55e-04 | 101 | 53 | 4 | M1979 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 6.43e-04 | 105 | 53 | 4 | MM15206 | |
| Pathway | WP_THERMOGENESIS | 7.15e-04 | 108 | 53 | 4 | M39746 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 7.15e-04 | 108 | 53 | 4 | M17034 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 8.47e-04 | 113 | 53 | 4 | M16817 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 9.04e-04 | 115 | 53 | 4 | M9387 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 1.09e-03 | 313 | 53 | 6 | M27867 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.15e-03 | 211 | 53 | 5 | MM14502 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 1.35e-03 | 219 | 53 | 5 | M29836 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 1.41e-03 | 15 | 53 | 2 | MM15031 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 1.59e-03 | 134 | 53 | 4 | M29840 | |
| Pathway | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | 1.61e-03 | 16 | 53 | 2 | M8245 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 1.73e-03 | 137 | 53 | 4 | MM15182 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.24e-03 | 147 | 53 | 4 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.46e-03 | 151 | 53 | 4 | M39329 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 2.50e-03 | 252 | 53 | 5 | MM15585 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 2.65e-03 | 154 | 53 | 4 | MM15974 | |
| Pathway | WP_CANCER_PATHWAYS | 2.75e-03 | 507 | 53 | 7 | M48302 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 2.77e-03 | 156 | 53 | 4 | M39475 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY | 2.78e-03 | 21 | 53 | 2 | MM15347 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY | 2.78e-03 | 21 | 53 | 2 | M27645 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 2.84e-03 | 157 | 53 | 4 | M4904 | |
| Pathway | KEGG_PURINE_METABOLISM | 2.97e-03 | 159 | 53 | 4 | M14314 | |
| Pathway | BIOCARTA_CASPASE_PATHWAY | 3.05e-03 | 22 | 53 | 2 | M17902 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 3.34e-03 | 23 | 53 | 2 | MM15033 | |
| Pathway | WP_CHEMOKINE_SIGNALING | 3.39e-03 | 165 | 53 | 4 | M39400 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 3.63e-03 | 24 | 53 | 2 | MM15992 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 3.63e-03 | 24 | 53 | 2 | M39643 | |
| Pathway | WP_PURINE_METABOLISM | 3.85e-03 | 171 | 53 | 4 | MM15909 | |
| Pathway | BIOCARTA_CASPASE_PATHWAY | 3.94e-03 | 25 | 53 | 2 | MM1359 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 4.27e-03 | 411 | 53 | 6 | M735 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 4.49e-03 | 289 | 53 | 5 | MM15057 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 4.92e-03 | 28 | 53 | 2 | M10679 | |
| Pathway | WP_CHEMOKINE_SIGNALING_PATHWAY | 5.00e-03 | 184 | 53 | 4 | MM15943 | |
| Pathway | KEGG_CHEMOKINE_SIGNALING_PATHWAY | 5.39e-03 | 188 | 53 | 4 | M4844 | |
| Pubmed | 9.62e-13 | 16 | 80 | 6 | 17567809 | ||
| Pubmed | 3.24e-09 | 9 | 80 | 4 | 12503609 | ||
| Pubmed | Role of the calcium modulated cyclases in the development of the retinal projections. | 3.24e-09 | 9 | 80 | 4 | 17229090 | |
| Pubmed | Purification and characterization of a soluble form of mammalian adenylyl cyclase. | 5.39e-09 | 10 | 80 | 4 | 8663304 | |
| Pubmed | 5.39e-09 | 10 | 80 | 4 | 16615126 | ||
| Pubmed | Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. | 5.39e-09 | 10 | 80 | 4 | 11884542 | |
| Pubmed | 8.46e-09 | 11 | 80 | 4 | 10089566 | ||
| Pubmed | 8.46e-09 | 11 | 80 | 4 | 10808179 | ||
| Pubmed | Expression of adenylyl cyclase mRNAs in the denervated and in the developing mouse skeletal muscle. | 1.27e-08 | 12 | 80 | 4 | 9611134 | |
| Pubmed | 1.27e-08 | 12 | 80 | 4 | 10807185 | ||
| Pubmed | Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. | 2.55e-08 | 14 | 80 | 4 | 14993377 | |
| Pubmed | Adenylyl cyclase 6 plays a minor role in the mouse inner ear and retina. | 4.68e-08 | 4 | 80 | 3 | 37127773 | |
| Pubmed | 1.17e-07 | 5 | 80 | 3 | 21228062 | ||
| Pubmed | Mapping of adenylyl cyclase genes type I, II, III, IV, V, and VI in mouse. | 2.33e-07 | 6 | 80 | 3 | 7766992 | |
| Pubmed | Expression and regulation of adenylyl cyclase isoforms in the human adrenal gland. | 2.33e-07 | 6 | 80 | 3 | 11549699 | |
| Pubmed | 4.07e-07 | 7 | 80 | 3 | 12613887 | ||
| Pubmed | Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS. | 9.75e-07 | 9 | 80 | 3 | 9417641 | |
| Pubmed | 1.91e-06 | 11 | 80 | 3 | 11299302 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 34638692 | ||
| Pubmed | Ubiquitous Gasp1 overexpression in mice leads mainly to a hypermuscular phenotype. | 5.23e-06 | 2 | 80 | 2 | 23046573 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 18164588 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 23609114 | ||
| Pubmed | Adenylyl cyclase type 5 protein expression during cardiac development and stress. | 5.23e-06 | 2 | 80 | 2 | 19734365 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 31009605 | ||
| Pubmed | Usher's Syndrome Type II: A Comparative Study of Genetic Mutations and Vestibular System Evaluation. | 5.23e-06 | 2 | 80 | 2 | 28653555 | |
| Pubmed | Role and Association of Inflammatory and Apoptotic Caspases in Renal Tubulointerstitial Fibrosis. | 5.23e-06 | 2 | 80 | 2 | 27643624 | |
| Pubmed | The mouse ZFH-4 protein contains four homeodomains and twenty-two zinc fingers. | 5.23e-06 | 2 | 80 | 2 | 10873665 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 17068292 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 31162142 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 20431059 | ||
| Pubmed | Stimulation of renin secretion by catecholamines is dependent on adenylyl cyclases 5 and 6. | 5.23e-06 | 2 | 80 | 2 | 21282557 | |
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 10481931 | ||
| Pubmed | 5.23e-06 | 2 | 80 | 2 | 15671307 | ||
| Pubmed | 5.23e-06 | 15 | 80 | 3 | 7937899 | ||
| Pubmed | cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. | 5.23e-06 | 15 | 80 | 3 | 2165385 | |
| Pubmed | Interaction of Gsalpha with the cytosolic domains of mammalian adenylyl cyclase. | 1.57e-05 | 3 | 80 | 2 | 9268375 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 31173603 | ||
| Pubmed | PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome. | 1.57e-05 | 3 | 80 | 2 | 20440071 | |
| Pubmed | Caspase-7 deficiency protects from endotoxin-induced lymphocyte apoptosis and improves survival. | 1.57e-05 | 3 | 80 | 2 | 19168786 | |
| Pubmed | Dynamic regulation of cAMP synthesis through anchored PKA-adenylyl cyclase V/VI complexes. | 1.57e-05 | 3 | 80 | 2 | 16973443 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 27826057 | ||
| Pubmed | Chromosomal mapping of human adenylyl cyclase genes type III, type V and type VI. | 1.57e-05 | 3 | 80 | 2 | 8034296 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 24898256 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 29142287 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 17480121 | ||
| Pubmed | Gq-mediated Ca2+ signals inhibit adenylyl cyclases 5/6 in vascular smooth muscle cells. | 1.57e-05 | 3 | 80 | 2 | 19889965 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 15677459 | ||
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 16434480 | ||
| Pubmed | AMCase is a crucial regulator of type 2 immune responses to inhaled house dust mites. | 1.57e-05 | 3 | 80 | 2 | 26038565 | |
| Pubmed | Regulation of type V adenylate cyclase by Ric8a, a guanine nucleotide exchange factor. | 1.57e-05 | 3 | 80 | 2 | 17593019 | |
| Pubmed | 1.57e-05 | 3 | 80 | 2 | 22147658 | ||
| Pubmed | 3.02e-05 | 529 | 80 | 8 | 14621295 | ||
| Pubmed | Ascorbic acid is a regulator of the intracellular cAMP concentration: old molecule, new functions? | 3.13e-05 | 4 | 80 | 2 | 18835269 | |
| Pubmed | Calpain activation is upstream of caspases in radiation-induced apoptosis. | 3.13e-05 | 4 | 80 | 2 | 9894612 | |
| Pubmed | Caspase-7 activation by the Nlrc4/Ipaf inflammasome restricts Legionella pneumophila infection. | 3.13e-05 | 4 | 80 | 2 | 19343209 | |
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 26401052 | ||
| Pubmed | Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism. | 3.13e-05 | 4 | 80 | 2 | 18463160 | |
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 23300874 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 20502675 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 37066759 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 22464733 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 23842570 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 9837723 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 20301515 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 23055499 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 25049074 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 25406310 | ||
| Pubmed | 3.13e-05 | 4 | 80 | 2 | 27339879 | ||
| Pubmed | 3.68e-05 | 28 | 80 | 3 | 28218627 | ||
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 4.10e-05 | 29 | 80 | 3 | 15203201 | |
| Pubmed | 5.03e-05 | 31 | 80 | 3 | 12626323 | ||
| Pubmed | Targeted peptidecentric proteomics reveals caspase-7 as a substrate of the caspase-1 inflammasomes. | 5.20e-05 | 5 | 80 | 2 | 18667412 | |
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 19433454 | ||
| Pubmed | Caspase-mediated cleavage of the ubiquitin-protein ligase Nedd4 during apoptosis. | 5.20e-05 | 5 | 80 | 2 | 9593687 | |
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 17906286 | ||
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 9654089 | ||
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 24334608 | ||
| Pubmed | Mammalian adenylyl cyclase family members are randomly located on different chromosomes. | 5.20e-05 | 5 | 80 | 2 | 7959689 | |
| Pubmed | Scaffold protein harmonin (USH1C) provides molecular links between Usher syndrome type 1 and type 2. | 5.20e-05 | 5 | 80 | 2 | 16301216 | |
| Pubmed | 5.20e-05 | 5 | 80 | 2 | 19713535 | ||
| Pubmed | Non-apoptotic role for caspase-7 in hair follicles and the surrounding tissue. | 5.20e-05 | 5 | 80 | 2 | 26253163 | |
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 6.08e-05 | 33 | 80 | 3 | 25713288 | |
| Pubmed | Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. | 7.79e-05 | 6 | 80 | 2 | 12888622 | |
| Pubmed | The ER-Localized Protein DFCP1 Modulates ER-Lipid Droplet Contact Formation. | 7.79e-05 | 6 | 80 | 2 | 30970241 | |
| Pubmed | Growth inhibition of cytosolic Salmonella by caspase-1 and caspase-11 precedes host cell death. | 7.79e-05 | 6 | 80 | 2 | 27808091 | |
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 25738962 | ||
| Pubmed | 7.79e-05 | 6 | 80 | 2 | 24944202 | ||
| Pubmed | 1.09e-04 | 7 | 80 | 2 | 12244174 | ||
| Pubmed | 1.09e-04 | 7 | 80 | 2 | 11526440 | ||
| Pubmed | 1.09e-04 | 7 | 80 | 2 | 9219695 | ||
| Pubmed | 1.09e-04 | 7 | 80 | 2 | 20058854 | ||
| Pubmed | 1.09e-04 | 7 | 80 | 2 | 38109525 | ||
| Pubmed | 1.09e-04 | 7 | 80 | 2 | 21212183 | ||
| Pubmed | 1.09e-04 | 7 | 80 | 2 | 31251782 | ||
| Pubmed | 1.45e-04 | 8 | 80 | 2 | 9038361 | ||
| Pubmed | Microarray-based mutation analysis of 183 Spanish families with Usher syndrome. | 1.45e-04 | 8 | 80 | 2 | 19683999 | |
| Pubmed | Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia. | 1.45e-04 | 8 | 80 | 2 | 20802146 | |
| Pubmed | 1.45e-04 | 8 | 80 | 2 | 12480175 | ||
| Pubmed | Cleavage of human cytosolic phospholipase A2 by caspase-1 (ICE) and caspase-8 (FLICE). | 1.45e-04 | 8 | 80 | 2 | 9875225 | |
| Pubmed | 1.86e-04 | 9 | 80 | 2 | 8962078 | ||
| GeneFamily | Adenylate cyclases|Deafness associated genes | 2.27e-08 | 10 | 60 | 4 | 53 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 6.47e-05 | 4 | 60 | 2 | 1244 | |
| GeneFamily | Caspases|Caspase recruitment domain containing | 8.25e-04 | 13 | 60 | 2 | 468 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.11e-03 | 15 | 60 | 2 | 529 | |
| GeneFamily | Zinc fingers C2H2-type|Kruppel like factors | 1.60e-03 | 18 | 60 | 2 | 624 | |
| GeneFamily | Olfactory receptors, family 2 | 6.28e-03 | 113 | 60 | 3 | 149 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | PLXNA3 GPRASP1 MUC19 NTNG1 ZFHX3 ACVR1B GABBR2 SHISAL1 ADCY2 | 1.75e-05 | 506 | 77 | 9 | M39067 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.47e-05 | 196 | 77 | 6 | M3008 | |
| Coexpression | NABA_MATRISOME | GPC1 PLXNA3 HGF HMCN2 ADAMTS7 MATN2 WFIKKN2 MUC19 NTNG1 BMPER SMOC1 USH2A | 4.27e-05 | 1026 | 77 | 12 | M5889 |
| Coexpression | GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_UP | 5.67e-05 | 139 | 77 | 5 | M485 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | 6.66e-05 | 465 | 77 | 8 | M39066 | |
| Coexpression | SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP | 6.78e-05 | 27 | 77 | 3 | M4447 | |
| Coexpression | DESCARTES_ORGANOGENESIS_CHONDROCYTES_AND_OSTEOBLASTS | 7.57e-05 | 28 | 77 | 3 | MM3665 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | DCAF12L1 ZFHX4 SLC26A7 ZNF423 MATN2 KLF14 NTNG1 DPYSL4 ZFHX3 BMPER ADGRV1 ADGRL2 ADCY2 | 3.61e-06 | 791 | 75 | 13 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 3.42e-05 | 52 | 75 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.45e-05 | 115 | 75 | 5 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.16e-05 | 118 | 75 | 5 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 6.43e-05 | 61 | 75 | 4 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k3_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | 6.71e-05 | 388 | 75 | 8 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 9.35e-05 | 407 | 75 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | NPC1 GREB1L USP53 HGF DCAF12L1 ZFHX4 MATN2 TRPS1 NTNG1 SMOC1 ADCY2 | 1.06e-04 | 797 | 75 | 11 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500 | 1.18e-04 | 421 | 75 | 8 | gudmap_developingKidney_e15.5_Peripheral blastema_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_500 | 1.25e-04 | 137 | 75 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | PHOX2A DPP10 TBC1D30 ZFHX4 SLC26A7 ZNF423 TRPS1 NTNG1 DPYSL4 ZFHX3 BMPER | 1.34e-04 | 818 | 75 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.20e-04 | 243 | 75 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k3 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.53e-04 | 354 | 75 | 7 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500 | 3.00e-04 | 483 | 75 | 8 | Facebase_RNAseq_e9.5_Maxillary Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 3.36e-04 | 371 | 75 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | 3.58e-04 | 95 | 75 | 4 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | HGF ZFHX4 TRPS1 VPS13A NTNG1 BMPER SMOC1 SHISAL1 ADCY2 ADCY5 | 3.73e-04 | 772 | 75 | 10 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | GREB1L HGF SLC26A7 ZNF423 MROH2A MATN2 TRPS1 NTNG1 SMOC1 ADCY2 | 3.77e-04 | 773 | 75 | 10 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#3 | 4.13e-04 | 384 | 75 | 7 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K3 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | 4.40e-04 | 388 | 75 | 7 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#5 | 4.87e-04 | 103 | 75 | 4 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | HGF DPP10 TBC1D30 ZFHX4 SLC26A7 TRPS1 VPS13A NTNG1 SMOC1 ADCY5 | 5.22e-04 | 806 | 75 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | ZFHX4 SLC26A7 SLC27A1 WFIKKN2 TRPS1 NTNG1 DPYSL4 BMPER ADGRV1 ADCY2 SP140 | 5.60e-04 | 967 | 75 | 11 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000 | ZFHX4 SLC26A7 WFIKKN2 TRPS1 NTNG1 DPYSL4 BMPER SMOC1 ADCY2 ALX4 SP140 | 5.64e-04 | 968 | 75 | 11 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | ZFHX4 WFIKKN2 TRPS1 NTNG1 ZFHX3 BMPER ADGRV1 SMOC1 SHISAL1 ADCY2 SP140 | 5.89e-04 | 973 | 75 | 11 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | 5.93e-04 | 408 | 75 | 7 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.24e-04 | 110 | 75 | 4 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.36e-04 | 195 | 75 | 5 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k4 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | GREB1L HGF ZFHX4 MATN2 TRPS1 BMPER SMOC1 ADGRL2 ADCY2 PGGT1B | 6.38e-04 | 827 | 75 | 10 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | 6.65e-04 | 416 | 75 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 6.84e-04 | 418 | 75 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K1 | 7.87e-04 | 117 | 75 | 4 | gudmap_RNAseq_e15.5_Mesangium_2500_K1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-08 | 160 | 79 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-08 | 160 | 79 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-07 | 184 | 79 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-07 | 184 | 79 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-07 | 184 | 79 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.31e-06 | 195 | 79 | 6 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-06 | 196 | 79 | 6 | 1f47916c2663bd88c1e7c19c6a7688f4c7173ad2 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 9.44e-06 | 159 | 79 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.23e-05 | 168 | 79 | 5 | 6a233045638cb83dab64789b996b7598c325001e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-05 | 177 | 79 | 5 | 30f82b04e48940bfcaf2c22677efe6d57ae3f1a7 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 1.96e-05 | 185 | 79 | 5 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.01e-05 | 186 | 79 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-05 | 188 | 79 | 5 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.46e-05 | 194 | 79 | 5 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.46e-05 | 194 | 79 | 5 | fb80a0271ccb1cb3f954ebcf2c5945cb6adb6b8c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.52e-05 | 195 | 79 | 5 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.59e-05 | 196 | 79 | 5 | 308fa54385ca34e9e590967d4553b84aad96c92f | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-05 | 199 | 79 | 5 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.85e-05 | 200 | 79 | 5 | be527df943a8cedc6452ecef3cafc282db34ceb8 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.85e-05 | 200 | 79 | 5 | d254f6634895486f81d7a8b6f006fbc2679eaa5b | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.85e-05 | 200 | 79 | 5 | 8e41a484038216f0c2ad258fd46c0e702a4bb8bf | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 200 | 79 | 5 | c935caef2988f165e96d8f1ef99ae8963ab9377f | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.43e-05 | 116 | 79 | 4 | f2bf9599040f43b5ea8724841d7b71c0a859c016 | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.43e-05 | 116 | 79 | 4 | b0a3c109c5f20ab699e53bf8ab3903d102f5f315 | |
| ToppCell | Thalamus|World / BrainAtlas - Mouse McCarroll V32 | 5.43e-05 | 116 | 79 | 4 | 5ddfb2dd5459ff6d7ae38163a38eae64fda283b7 | |
| ToppCell | LPS-IL1RA-Endothelial-Mes-Like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.61e-05 | 117 | 79 | 4 | 5a23770806b4612bed4ae6fd716abdec7f7f56c6 | |
| ToppCell | TCGA-Uterus|World / Sample_Type by Project: Shred V9 | 1.26e-04 | 144 | 79 | 4 | 7efb45286ebf2dbfb9125fd6373f28dccb029a2e | |
| ToppCell | E16.5-samps-Myeloid-Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.39e-04 | 148 | 79 | 4 | cd5f697d8c2f272be1f3f52a05446749278431c5 | |
| ToppCell | E16.5-samps-Myeloid-Macrophage-CD163+_Macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.39e-04 | 148 | 79 | 4 | 56e146980a71b5ca655118ae13310c5949220d4a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-cortical_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.79e-04 | 158 | 79 | 4 | 1f94622186d8329357fa06785e03eeacf29ab1ce | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.93e-04 | 161 | 79 | 4 | 8aaca49b53a551395f4025ac4e535c7b0ce41a49 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.93e-04 | 161 | 79 | 4 | deb10628d258fb813c293f81fb71be8e383dc82a | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 2.02e-04 | 163 | 79 | 4 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | facs-Trachea-18m-Epithelial-glandular_epithelial-lung_secretory_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.07e-04 | 164 | 79 | 4 | cdb8cd2d6b369189ea77e4946738e2816d502e03 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.07e-04 | 164 | 79 | 4 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | facs-Trachea-18m-Epithelial-glandular_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.07e-04 | 164 | 79 | 4 | 5dbfcdd450f652b16d97da53b528d4584b0eabcf | |
| ToppCell | facs-Trachea-18m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.07e-04 | 164 | 79 | 4 | f1423f4434af4af9c60c8a5b0b0abec4a7df9401 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.16e-04 | 166 | 79 | 4 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | Endothelial-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.16e-04 | 166 | 79 | 4 | c286987ea4e511195607c87ec4529c2c2ed2122e | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-04 | 169 | 79 | 4 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.32e-04 | 169 | 79 | 4 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.37e-04 | 170 | 79 | 4 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-04 | 171 | 79 | 4 | 4e856441063e9825b6f87a1d3dd19c77dae4662c | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Slc17a6-Gad2-Th.Crhbp_(Supramammillary_Nucleus_(SuM)_Dopaminergic?,_Th+/Ddc+)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.51e-04 | 69 | 79 | 3 | 57df6acddf5fe7a1d6bc551c3e3de44102f2f1db | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Slc17a6-Gad2-Th.Crhbp_(Supramammillary_Nucleus_(SuM)_Dopaminergic?,_Th+/Ddc+)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.51e-04 | 69 | 79 | 3 | f9c1b871e594e57f0d6da3754f76ee41189f4633 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Slc17a6-Gad2-Th.Crhbp_(Supramammillary_Nucleus_(SuM)_Dopaminergic?,_Th+/Ddc+)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.51e-04 | 69 | 79 | 3 | ee2c7b86ef336c7d0c82a8950bf64457f2683732 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-04 | 174 | 79 | 4 | 742c73c9e090848b464323cb17579b86658c6792 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-04 | 174 | 79 | 4 | 7fed9722e64c60843092f2ba71256e3043011ef6 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D231|Adult / Lineage, Cell type, age group and donor | 2.59e-04 | 174 | 79 | 4 | 2dd647c4fdf99fd1f7b838efef01baf2cbc3446d | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.59e-04 | 174 | 79 | 4 | a62531ebf16b32b249168dca11b870f63a8aa81c | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.65e-04 | 175 | 79 | 4 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 175 | 79 | 4 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-progenitor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-04 | 176 | 79 | 4 | d5cee483d2a60f82fdc67ad447b589d022fe8c97 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-progenitor-Germ|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-04 | 176 | 79 | 4 | eea554ea75580f8dd5fefb57e7f33441ab86b884 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-04 | 177 | 79 | 4 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.76e-04 | 177 | 79 | 4 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.76e-04 | 177 | 79 | 4 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-04 | 177 | 79 | 4 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.82e-04 | 178 | 79 | 4 | 431e7557b8e8764e16e9e48368ce6bfa3c61561a | |
| ToppCell | droplet-Heart-4Chambers-21m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-04 | 178 | 79 | 4 | 3e8aacb27ed1a3c3978e21dddddd0828f8000692 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.95e-04 | 180 | 79 | 4 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.95e-04 | 180 | 79 | 4 | 1e819c5c87704ec6535dfeaae56561895e239d07 | |
| ToppCell | AT1-AT2_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.95e-04 | 180 | 79 | 4 | 3c7b2033821f9e34e2924bd8655f566edcbcc7d3 | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-04 | 180 | 79 | 4 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.01e-04 | 181 | 79 | 4 | 7e3bcfa2ba5b98a7df5854aa6e7a31e9a71faa8a | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.01e-04 | 181 | 79 | 4 | 2b9b460239d67fd480cee60820cdb306109d3567 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.01e-04 | 181 | 79 | 4 | 2a1aa4a0ec7bc367857beaff543135e4345c835b | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 3.07e-04 | 182 | 79 | 4 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.07e-04 | 182 | 79 | 4 | a1c0e4090a9e7aa4941a40c817d178de144888b6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.20e-04 | 184 | 79 | 4 | 7f6c8912677764d438ab0555faca344d74c2f483 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.34e-04 | 186 | 79 | 4 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.34e-04 | 186 | 79 | 4 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.40e-04 | 187 | 79 | 4 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.40e-04 | 187 | 79 | 4 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.40e-04 | 187 | 79 | 4 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.47e-04 | 188 | 79 | 4 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.54e-04 | 189 | 79 | 4 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.54e-04 | 189 | 79 | 4 | f75cebd4c3e54e297557449ba67ccc8d1a2a14f5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-04 | 190 | 79 | 4 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.62e-04 | 190 | 79 | 4 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 191 | 79 | 4 | 9c5d88f0d3c834c2419ec3da74652175153ba9df | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-04 | 191 | 79 | 4 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 3.69e-04 | 191 | 79 | 4 | 509d17d8ee0d028757ce0f2c9b97e5875f06f0ab | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 191 | 79 | 4 | a7494191a92984e5f53610bbbedd6714e9169e1c | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 3.76e-04 | 192 | 79 | 4 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_3|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.76e-04 | 192 | 79 | 4 | d88753b200d9c8da6716222d697ddf0a1548d6c8 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.76e-04 | 192 | 79 | 4 | 20ede290e01ad574afd122d72b59dbc52c595fad | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.84e-04 | 193 | 79 | 4 | 7cd9671e0ac64f7f3607f564485c63abbb7e7a63 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-04 | 193 | 79 | 4 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-04 | 193 | 79 | 4 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.84e-04 | 193 | 79 | 4 | 96c85b250d04b5f400512097d925061c6dc2906b | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.84e-04 | 193 | 79 | 4 | c5bd0ed6f57459e54d2463318e8d9b1879718e63 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-04 | 193 | 79 | 4 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 194 | 79 | 4 | 5d30d3d41d5f19cdf3077cc609aa2738762cb8c5 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-MYL4+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.99e-04 | 195 | 79 | 4 | dba2a87efd7e067c094c4b367feb4138cab62735 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.99e-04 | 195 | 79 | 4 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.99e-04 | 195 | 79 | 4 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.07e-04 | 196 | 79 | 4 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | 11.5-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class | 4.07e-04 | 196 | 79 | 4 | 05530fe7a5681c2f39b95016cd22ef99d6ac0430 | |
| ToppCell | ILEUM-non-inflamed-(9)_Enteric_neurons|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.07e-04 | 196 | 79 | 4 | 998aa523555ed6bc9c1b5cacbf7ba77c7b218e6b | |
| Drug | 2',5'-dd3'-FSBA | 2.50e-08 | 10 | 77 | 4 | CID003081206 | |
| Drug | NC-5Z | 2.50e-08 | 10 | 77 | 4 | CID003035914 | |
| Drug | AC1NY9KD | 3.92e-08 | 11 | 77 | 4 | CID005771741 | |
| Drug | AC1L40QM | 3.92e-08 | 11 | 77 | 4 | CID000099213 | |
| Drug | B-Mlvp | 3.92e-08 | 11 | 77 | 4 | CID000195648 | |
| Drug | FCE 23884 | 8.45e-08 | 13 | 77 | 4 | CID000065898 | |
| Drug | practolol | 1.55e-07 | 37 | 77 | 5 | CID000004883 | |
| Drug | BMY 42393 | 1.60e-07 | 15 | 77 | 4 | CID000131961 | |
| Drug | Ro 41-9067 | 4.51e-07 | 19 | 77 | 4 | CID000125800 | |
| Drug | SK&F 82958 | 4.51e-07 | 19 | 77 | 4 | ctd:C071262 | |
| Drug | reproterol | 6.93e-07 | 21 | 77 | 4 | CID000025654 | |
| Drug | GSK835726 | 8.44e-07 | 22 | 77 | 4 | CID005311268 | |
| Drug | beta-CNA | 1.02e-06 | 23 | 77 | 4 | CID005486190 | |
| Drug | Scpb | 1.02e-06 | 23 | 77 | 4 | CID000123843 | |
| Drug | NAIN | 1.22e-06 | 24 | 77 | 4 | CID000195228 | |
| Drug | TL-99 | 1.22e-06 | 24 | 77 | 4 | CID000122132 | |
| Drug | trimetoquinol | 1.22e-06 | 24 | 77 | 4 | CID000005581 | |
| Drug | AC1L8VEV | 1.22e-06 | 24 | 77 | 4 | CID000433433 | |
| Drug | PD 81,723 | 1.45e-06 | 25 | 77 | 4 | CID000122028 | |
| Drug | octimibate | 1.45e-06 | 25 | 77 | 4 | CID000065676 | |
| Drug | metaproterenol | 1.71e-06 | 26 | 77 | 4 | CID000004086 | |
| Drug | SM-10906 | 2.00e-06 | 27 | 77 | 4 | CID006442261 | |
| Drug | AC1L1EV8 | 2.06e-06 | 8 | 77 | 3 | CID000002964 | |
| Drug | tetrahydrofurfuryl alcohol | 2.33e-06 | 28 | 77 | 4 | CID000007360 | |
| Drug | prenalterol | 2.33e-06 | 28 | 77 | 4 | CID000042396 | |
| Drug | desacetylnantradol | 2.33e-06 | 28 | 77 | 4 | CID000125211 | |
| Drug | Nocloprostum | 2.33e-06 | 28 | 77 | 4 | CID006435380 | |
| Drug | tolazoline | 2.69e-06 | 29 | 77 | 4 | CID000005504 | |
| Drug | etazolate | 2.69e-06 | 29 | 77 | 4 | CID000003277 | |
| Drug | 14,15-dihydroforskolin | 3.08e-06 | 9 | 77 | 3 | CID000194193 | |
| Drug | AC1N2DGT | 3.10e-06 | 30 | 77 | 4 | CID004045015 | |
| Drug | fenoldopam | 3.95e-06 | 70 | 77 | 5 | CID000003340 | |
| Drug | dopexamine | 4.05e-06 | 32 | 77 | 4 | CID000055483 | |
| Drug | carbonyl cyanide m-chlorophenylhydrazone | 4.18e-06 | 125 | 77 | 6 | CID000002603 | |
| Drug | 4-isopropylaniline | 4.24e-06 | 71 | 77 | 5 | CID000007464 | |
| Drug | 6,7-ADTN | 4.59e-06 | 33 | 77 | 4 | CID000003153 | |
| Drug | phosphonate analog | 4.59e-06 | 33 | 77 | 4 | CID000475766 | |
| Drug | Ts-I | 5.56e-06 | 75 | 77 | 5 | CID000445278 | |
| Drug | AC1L1DSZ | 6.56e-06 | 36 | 77 | 4 | CID000002494 | |
| Drug | chlorthalidone | 6.56e-06 | 36 | 77 | 4 | CID000002732 | |
| Drug | Tyr-D-Ala-Gly-N-methyl-Phe-Gly-ol | 7.65e-06 | 80 | 77 | 5 | CID004488326 | |
| Drug | 2g6p | 8.18e-06 | 38 | 77 | 4 | CID002740174 | |
| Drug | AC1L1XPX | 8.18e-06 | 38 | 77 | 4 | CID000011606 | |
| Drug | DPDPE | 8.64e-06 | 82 | 77 | 5 | CID000104787 | |
| Drug | dimaprit | 1.01e-05 | 40 | 77 | 4 | CID000003077 | |
| Drug | AC1L1BJN | 1.04e-05 | 13 | 77 | 3 | CID000001467 | |
| Drug | nantradol hydrochloride | 1.04e-05 | 13 | 77 | 3 | CID000047652 | |
| Drug | sclareol glycol | 1.04e-05 | 13 | 77 | 3 | CID000091915 | |
| Drug | AC1NIP3C | 1.11e-05 | 41 | 77 | 4 | CID004834553 | |
| Drug | AC1L1I54 | 1.11e-05 | 41 | 77 | 4 | CID000004426 | |
| Drug | 2-amino-4-phosphonobutyric acid | 1.44e-05 | 91 | 77 | 5 | CID000002207 | |
| Drug | TLCK | 1.60e-05 | 158 | 77 | 6 | CID000004427 | |
| Drug | SKF 75670 | 1.64e-05 | 15 | 77 | 3 | CID000173870 | |
| Drug | AC1L2AAS | 1.64e-05 | 15 | 77 | 3 | CID000068714 | |
| Drug | benzeneacetamide | 1.77e-05 | 46 | 77 | 4 | CID000007680 | |
| Drug | betaxolol | 2.10e-05 | 48 | 77 | 4 | CID000002369 | |
| Drug | procaterol | 2.10e-05 | 48 | 77 | 4 | CID000004916 | |
| Drug | Neomigran | 2.10e-05 | 48 | 77 | 4 | CID000003066 | |
| Drug | copper | 2.21e-05 | 571 | 77 | 10 | CID000023978 | |
| Drug | U754 | 2.44e-05 | 17 | 77 | 3 | CID000062824 | |
| Drug | fentanyl isothiocyanate | 2.44e-05 | 17 | 77 | 3 | CID000084008 | |
| Drug | San 21009 | 2.44e-05 | 17 | 77 | 3 | CID000152662 | |
| Drug | Gastrin tetrapeptide | 2.47e-05 | 50 | 77 | 4 | CID000005415 | |
| Drug | AC1L1FA8 | 2.47e-05 | 50 | 77 | 4 | CID000003150 | |
| Drug | racemic timolol | 2.68e-05 | 51 | 77 | 4 | CID000005478 | |
| Drug | NSC97113 | 2.68e-05 | 51 | 77 | 4 | CID000001869 | |
| Drug | endrine | 3.01e-05 | 106 | 77 | 5 | CID000003048 | |
| Drug | propanol | 3.12e-05 | 53 | 77 | 4 | CID000001031 | |
| Drug | indapamide | 3.12e-05 | 53 | 77 | 4 | CID000003702 | |
| Drug | L-quisqualic acid | 3.34e-05 | 180 | 77 | 6 | CID000001209 | |
| Drug | saccharin | 3.36e-05 | 54 | 77 | 4 | CID000005143 | |
| Drug | FICA | 3.38e-05 | 3 | 77 | 2 | CID000448573 | |
| Drug | AC1L3XQA | 3.47e-05 | 19 | 77 | 3 | CID000124009 | |
| Drug | SKF 38393 | 3.60e-05 | 110 | 77 | 5 | CID000001242 | |
| Drug | AC1MUNZL | 3.89e-05 | 56 | 77 | 4 | CID003643892 | |
| Drug | fenoterol | 3.89e-05 | 56 | 77 | 4 | CID000003343 | |
| Drug | Dvdavp | 4.07e-05 | 20 | 77 | 3 | CID006441676 | |
| Drug | YM435 | 4.07e-05 | 20 | 77 | 3 | CID000132119 | |
| Drug | NSC-4928 | 4.47e-05 | 58 | 77 | 4 | CID000221086 | |
| Drug | 6-fluoronorepinephrine | 4.73e-05 | 21 | 77 | 3 | CID000001862 | |
| Drug | etorphine | 4.78e-05 | 59 | 77 | 4 | CID000026721 | |
| Drug | Vasotocin | 4.78e-05 | 59 | 77 | 4 | CID000024774 | |
| Drug | AC1Q3G0K | 5.11e-05 | 60 | 77 | 4 | CID000002087 | |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; PC3; HT_HG-U133A | 5.23e-05 | 195 | 77 | 6 | 4309_UP | |
| Drug | Kawain [500-64-1]; Up 200; 17.4uM; PC3; HT_HG-U133A | 5.38e-05 | 196 | 77 | 6 | 7369_UP | |
| Drug | iohexol | 5.45e-05 | 61 | 77 | 4 | CID000003730 | |
| Drug | otenzepad | 5.45e-05 | 61 | 77 | 4 | CID000107867 | |
| Drug | Aminocaproic acid [60-32-2]; Down 200; 30.4uM; HL60; HT_HG-U133A | 5.53e-05 | 197 | 77 | 6 | 3122_DN | |
| Drug | potassium phosphate | 5.68e-05 | 121 | 77 | 5 | CID000024450 | |
| Drug | Reserpine [50-55-5]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 5.69e-05 | 198 | 77 | 6 | 3341_UP | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Up 200; 9uM; MCF7; HT_HG-U133A | 5.69e-05 | 198 | 77 | 6 | 5263_UP | |
| Drug | 8-iso Misoprostol | 5.81e-05 | 62 | 77 | 4 | CID004183806 | |
| Drug | Argipressin | 5.81e-05 | 62 | 77 | 4 | CID000008230 | |
| Drug | 8-phenyltheophylline | 5.81e-05 | 62 | 77 | 4 | CID000001922 | |
| Drug | naphthalene-diisocyanate | 5.81e-05 | 62 | 77 | 4 | CID003033874 | |
| Drug | d 1b | 5.81e-05 | 62 | 77 | 4 | CID000449090 | |
| Drug | CAS 66104-23-2 | 6.19e-05 | 63 | 77 | 4 | CID000004745 | |
| Drug | alprenolol | 6.59e-05 | 64 | 77 | 4 | CID000002119 | |
| Drug | AAGTP | 6.59e-05 | 64 | 77 | 4 | CID000656407 | |
| Drug | xanthine amine congener | 6.59e-05 | 64 | 77 | 4 | CID000005697 | |
| Disease | body fat percentage | 4.10e-05 | 488 | 77 | 8 | EFO_0007800 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 4.70e-05 | 364 | 77 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | Rett Syndrome, Atypical | 6.69e-05 | 5 | 77 | 2 | C2748910 | |
| Disease | response to antidepressant | 9.96e-05 | 176 | 77 | 5 | GO_0036276 | |
| Disease | ovarian carcinoma | 1.96e-04 | 321 | 77 | 6 | EFO_0001075 | |
| Disease | urinary 6‑hydroxymelatonin sulfate to creatinine ratio | 2.98e-04 | 10 | 77 | 2 | EFO_0021488 | |
| Disease | body weight | NPC1 ZNF423 TRPS1 NTNG1 DPYSL4 ZFHX3 ADGRV1 SMOC1 ZFYVE1 ADCY5 ADCY6 | 4.17e-04 | 1261 | 77 | 11 | EFO_0004338 |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 4.89e-04 | 139 | 77 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 5.99e-04 | 14 | 77 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | HGF XKR9 ADAMTS7 SEM1 ZNF423 ZFHX3 ADGRV1 MED23 ADGRL2 ALX4 TG | 7.14e-04 | 1345 | 77 | 11 | EFO_0010736 |
| Disease | synophrys measurement | 7.58e-04 | 68 | 77 | 3 | EFO_0007906 | |
| Disease | body fat percentage, type 2 diabetes mellitus | 8.91e-04 | 17 | 77 | 2 | EFO_0007800, MONDO_0005148 | |
| Disease | osteoporosis | 9.32e-04 | 73 | 77 | 3 | EFO_0003882 | |
| Disease | Leukemia, Myelocytic, Acute | 1.11e-03 | 173 | 77 | 4 | C0023467 | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 1.12e-03 | 19 | 77 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | alpha-tocopherol measurement | 1.24e-03 | 20 | 77 | 2 | EFO_0007898 | |
| Disease | haptoglobin measurement | 1.37e-03 | 21 | 77 | 2 | EFO_0004640 | |
| Disease | temperament and character inventory | 1.79e-03 | 24 | 77 | 2 | EFO_0004825 | |
| Disease | chromatid-type aberration frequency | 2.10e-03 | 26 | 77 | 2 | EFO_0009862 | |
| Disease | upper face morphology measurement | 2.11e-03 | 97 | 77 | 3 | EFO_0010949 | |
| Disease | Disorder of eye | 2.33e-03 | 212 | 77 | 4 | C0015397 | |
| Disease | cortical thickness | 2.42e-03 | 1113 | 77 | 9 | EFO_0004840 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 2.43e-03 | 28 | 77 | 2 | DOID:1094 (implicated_via_orthology) | |
| Disease | 1,5 anhydroglucitol measurement | 2.61e-03 | 29 | 77 | 2 | EFO_0008009 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MNAETCVSYCESPAA | 1 | Q9H161 | |
| EIGSQVEMECICYSF | 246 | A8MTB9 | |
| CSMFFSFCEKNVDYE | 931 | Q8NHU2 | |
| ASECIEDFNTMFSNC | 91 | Q58F21 | |
| YYQSCECVAVMFASI | 971 | O43306 | |
| QANYTCETDGACMVS | 41 | P36896 | |
| DYVECACSHMSVYAV | 5881 | Q8WXG9 | |
| MFGQTAEDYAFCCDL | 231 | A2A2Z9 | |
| ICDADPFQMENTDCY | 71 | O95490 | |
| VYKQVCASCHSMDFV | 116 | P08574 | |
| YHQSYDCVCVMFASV | 871 | P51828 | |
| ELYYQSCECVAVMFA | 1061 | O95622 | |
| SCECVAVMFASIANF | 1066 | O95622 | |
| ISCNFMKEQCTYFDA | 466 | Q8N608 | |
| YSAFCEDMDNVCHTL | 481 | Q9UKP4 | |
| NRNNFESEDYCMAVC | 346 | Q06481 | |
| ACADTSVFENAMYIC | 186 | Q8NG77 | |
| MSAAVACVDYFAADV | 1 | Q9BXK1 | |
| EYSCVNMDRSFACQC | 496 | O00339 | |
| YTCCTSEMEENLANR | 66 | P35052 | |
| VADAASYMCVAENQA | 2916 | Q8NDA2 | |
| YSSERMADNACVLFA | 71 | Q15012 | |
| MCSARAEYSNCGENE | 21 | Q9UNE0 | |
| ADFVFYNCSVLQSCM | 631 | P51805 | |
| ACADTSVFENAMYIC | 186 | A6NH00 | |
| CTAVAMYAEACSAVG | 1511 | Q7Z5P9 | |
| FDFTACHQSYSEMSC | 1191 | Q9ULK4 | |
| EYCAIKTCADNTMND | 281 | P14210 | |
| ACADTSVFENAMYIC | 186 | Q8NG76 | |
| HCEQCRQYMDFTSAS | 1441 | Q9C091 | |
| TSDCAQTFAFMCEFR | 141 | Q7Z442 | |
| SFANAMYNACRDVEA | 151 | O15118 | |
| DTYSHFMCATCQTGE | 671 | Q9QC07 | |
| VFMAYKDRCQCSDSQ | 166 | O14531 | |
| KDRCQCSDSQMYEIF | 171 | O14531 | |
| QSYDCVCVMFASIPD | 881 | Q08462 | |
| MSESFDCAKCNESLY | 1 | Q13643 | |
| ANCLDMQDFAEAFSC | 136 | Q9UJP4 | |
| DYATFYRSCVTDMCE | 576 | Q8N8U9 | |
| HMQEYACSCDVEEIF | 356 | P29466 | |
| CFYNEECNALFQTMS | 141 | Q7Z4T8 | |
| FDVIVYNDCSCAKMQ | 106 | P55210 | |
| DQNMAAKVFCCAYEE | 256 | O75899 | |
| MSAAVACLDYFAAEC | 1 | Q8TD94 | |
| FRDNVCLTYCDDMSV | 306 | Q5VU92 | |
| DCDQQIDSCTYEAMY | 721 | P22681 | |
| DEPSFSVAYANMCRC | 801 | O43432 | |
| CTFDDAFQCYPEVME | 241 | Q9NXZ2 | |
| SYSACAAQMFFCAVF | 91 | Q8NGF7 | |
| ICSAMETFCETVQFY | 221 | A6NES4 | |
| YMCNNECDASTPELA | 86 | Q9Y2I2 | |
| AENQTYMDCRAETSC | 586 | Q5JY77 | |
| EGSENDMRFVYCASC | 166 | P53609 | |
| QAEYCTEMGAAACTL | 116 | O75031 | |
| QDYVNMSDTICCSAS | 3326 | O75445 | |
| VFKYCCNETEFQAVM | 66 | Q3SXP7 | |
| MYCQDSNICAVFAVQ | 1 | Q6ZVN7 | |
| DCTFMVDNEAVYDIC | 206 | A6NHL2 | |
| MCAQYCISFADVEKA | 1 | Q9GZT4 | |
| EASETYTICSCNQMA | 571 | Q14246 | |
| MDQCYFENSLSTECI | 886 | Q70EK8 | |
| MGDFVVVYTDGCCSS | 136 | O60930 | |
| EDNMVTSYNCQFCDF | 516 | Q9UHF7 | |
| CASDGRSYESMCEYQ | 56 | Q9H4F8 | |
| ACFSDYRTPTMQECE | 2901 | Q86UP3 | |
| CVTDAVFQEMYICAS | 1496 | Q96RL7 | |
| FYGATECNCSIANMD | 386 | Q6PCB7 | |
| LNSYDSCVAAMEASA | 6 | O14813 | |
| YMCDVCQKRFAHEST | 411 | A6NJL1 | |
| CCDVSSDNQYLVMGS | 416 | A0A1W2PR48 | |
| AREACANEAATMATY | 2216 | Q8WWQ8 | |
| IECCETADEFYSTMG | 476 | Q9Y2I9 | |
| VTYSCVEEVDAAMCA | 81 | P51991 | |
| LMCQESYACSGTDEA | 16 | Q9HBF4 | |
| QSAYENEKCSCVMCF | 446 | Q13342 | |
| DDFMCDYCEDTFSQT | 261 | Q2M1K9 | |
| IIAASFACYCTNMEN | 266 | Q8TE54 | |
| AVRCMFYADTQSCTH | 2151 | P01266 | |
| STFVCKNCSQMFYTE | 836 | Q9H0D2 | |
| NFSQYAAIMVSCCAI | 161 | Q5GH70 | |
| CNECSASFASLQTYM | 81 | Q15911 | |
| NHFETYEACMLACMS | 366 | Q8TEU8 |